XMU-MP-2

N/A

Report date: 2022/01/12 16:52:28
NME

Base Information

Drug NameXMU-MP-2
Drug Alias NameXMU-MP-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BRK inhibitors
TargetsTyrosine-protein kinase BRK
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen University
China Registration ClassN/A

Develop Information

Active CompaniesXiamen University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A